Aortic Regurgitation Clinical Presentation

  • Author: Stanley S Wang, MD, JD, MPH; Chief Editor: Richard A Lange, MD   more...
 
Updated: Apr 2, 2012
 

History

Acute aortic regurgitation

The typical presentation of acute severe aortic regurgitation (AR) includes sudden, severe shortness of breath, rapidly developing heart failure, and chest pain if myocardial perfusion pressure is decreased or an aortic dissection is present. Because the LV is non-compliant in acute cases, the LV end-diastolic pressure is high resulting in a smaller diastolic gradient across the aortic valve and, in some cases, a short or minimal diastolic murmur on examination. Cases may be fulminant and lead to cardiogenic shock. Early surgical intervention is recommended in cases due to infective endocarditis, and emergent intervention is warranted in cases due to aortic dissection.

Chronic aortic regurgitation

Patients with chronic AR often have a long-standing asymptomatic period that may last for several years. A compensatory tachycardia may develop to maintain a large forward stroke volume, resulting in a decreased diastolic filling period. As a result, patients may be asymptomatic even with exercise. Over time, chronic volume overload eventually leads to LV dysfunction as the LV dilates. Significant deterioration of LV function may begin prior to the development of symptoms in up to one-fourth of patients, highlighting the importance of periodic echocardiographic surveillance.[5] Among patients with asymptomatic LV dysfunction, more than one-fourth develop symptoms within 1 year. Once symptoms arise, cardiac function usually worsens more rapidly and mortality may exceed 10% per year.

Symptoms of chronic severe AR include the following:

  • Palpitations, often described as the sensation of having forceful heart beats, due to widened pulse pressure with hyperdynamic circulation
  • Shortness of breath, which may not worsen with exertion in the early stages due to compensatory tachycardia with shortened diastole
  • Chest pain, if LV end-diastolic pressure compromises coronary perfusion pressure gradients
  • Sudden cardiac death, although this is uncommon (< 0.2%/y) in asymptomatic patients with preserved LV function
Next

Physical

Many classical physical examination findings have been described in patients with chronic severe AR. However, these findings may be minimally present (if at all) in patients with acute severe AR.

Manifestations of chronic severe AR are often the result of widened pulse pressure (ie, an exaggerated difference between systolic and diastolic blood pressure) because (1) of elevated stroke volume during systole and (2) the incompetent aortic valve allows the diastolic pressure within the aorta to fall significantly. Diastolic pressures are often lower than 60 mm Hg with pulse pressures (ie, the difference between the systolic and diastolic pressure) often exceeding 100 mm Hg, although younger patients with more compliant vessels may have a less widened pulse pressure. Many physical examination findings have associated eponyms.

  • Becker sign - Visible systolic pulsations of the retinal arterioles
  • Corrigan pulse ("water-hammer" pulse) - Abrupt distention and quick collapse on palpation of the peripheral arterial pulse
  • de Musset sign - Bobbing motion of the patient's head with each heartbeat
  • Hill sign - Popliteal cuff systolic blood pressure 40 mm Hg higher than brachial cuff systolic blood pressure
  • Duroziez sign - Systolic murmur over the femoral artery with proximal compression of the artery, and diastolic murmur over the femoral artery with distal compression of the artery
  • Müller sign - Visible systolic pulsations of the uvula
  • Quincke sign - Visible pulsations of the fingernail bed with light compression of the fingernail
  • Traube sign ("pistol-shot" pulse) - Booming systolic and diastolic sounds auscultated over the femoral artery

On palpation, the point of maximal impulse may be diffuse or hyperdynamic but is often displaced inferiorly and toward the axilla. Peripheral pulses are prominent or bounding. Auscultation may reveal an S3 gallop if LV dysfunction is present. The murmur of AR occurs in diastole, usually as a high-pitched sound that is loudest at the left sternal border. The duration of the murmur correlates better with the severity of AR than the loudness of the murmur. A functional systolic flow murmur may also be present because of increased stroke volume, although concurrent aortic stenosis may also be present. An Austin Flint murmur may be present at the cardiac apex in severe AR and is a low-pitched, mid-diastolic rumbling murmur due to blood jets from the AR striking the anterior leaflet of the mitral valve, which results in premature closure of the mitral leaflets.

In many cases, physical examination also reveals findings relating to the underlying cause. For example, there may be various embolic phenomena in patients with AR due to infective endocarditis or skeletal features suggestive of Marfan syndrome or a spondyloarthropathy if AR is due to these conditions.

Previous
Next

Causes

Acute aortic regurgitation

  • Infective endocarditis may lead to destruction or perforation of the aortic valve leaflet. A bulky vegetation can also interfere with proper coaptation of the valve leaflets or cause lead to frank prolapse or disruption of a leaflet (flail leaflet).
  • In acute ascending aortic dissection (type A), the retrograde proximal dissection undermines the suspensions of the aortic valve leaflets. Varying levels of aortic valve malcoaptation and prolapse occur.
  • Prosthetic valve malfunction can lead to AR.
  • Chest trauma may lead to a tear in the ascending aorta and disruption of the aortic valve support apparatus.

Chronic aortic regurgitation

  • Bicuspid aortic valve is the most common congenital lesion of the human heart and leads more commonly to progressive aortic stenosis, but is also the most common cause of isolated AR requiring aortic valve surgery. In addition, an associated aortopathy may be present, resulting in aortic dilation and/or dissection that worsens the AR.[8]
  • Connective tissue disorders, including Marfan syndrome, Ehlers-Danlos syndrome, floppy aortic valve, aortic valve prolapse, sinus of Valsalva aneurysm, and aortic annular fistula can all lead to significant AR.
  • Certain weight loss medications, such as fenfluramine and dexfenfluramine (commonly referred to as Phen-Fen), may induce degenerative valvular changes that result in chronic AR.
  • Rheumatic fever was a common cause of AR in the first half of the 20th century but has become less common in the United States, although it remains prevalent in some immigrant populations. Fibrotic changes cause thickening and retraction of the aortic valve leaflets, resulting in central valvular regurgitation. Leaflet fusion may occur, resulting in concurrent aortic stenosis. Associated rheumatic mitral valve disease is almost always present.
  • Ankylosing spondylitis often causes an aortitis that most frequently involves the aortic root with associated AR.[9] Further extension of the subaortic fibrotic process into the intraventricular septum may result in conduction system disease. Coronary and more distal aortic abnormalities are also seen in this condition.
  • Behcet disease rarely causes cardiac complications (< 5% of patients) but potential findings include proximal aortitis with AR as well as coronary artery disease.[10]
  • Giant cell arteritis is a systemic vasculitis that typically affects the extracranial branches of the carotid artery but may also cause aortic inflammation and AR (as well as coronary artery disease and LV dysfunction.[11]
  • Rheumatoid arthritis uncommonly causes granulomatous nodules to form within the aortic valve leaflets and, in rare cases, this may lead to clinical AR, although it is more commonly an incidental finding postmortem.[12]
  • Systemic lupus erythematosus can cause valvular fibrosis and consequent dysfunction, including AR.[13] Lupus is also associated with Libman-Sacks endocarditis, resulting in sterile verrucous valvular vegetations that can cause AR.[14, 15]
  • Takayasu arteritis can produce an aortitis in addition to aortic valve (and coronary) involvement. The aortitis may increase the risk of prosthetic valve detachment, leading some to advocate for concurrent aortic root replacement in patients undergoing valve surgery.[16]
  • Whipple disease has been reported in the literature in association with AR or aortic valve endocarditis.[17]
Previous
 
 
Contributor Information and Disclosures
Author

Stanley S Wang, MD, JD, MPH  Clinical Cardiologist, Austin Heart South; Director of Legislative Affairs, Austin Heart; Director, Sleep Disorders Center at Heart Hospital of Austin; Assistant Professor of Medicine (Adjunct), University of North Carolina School of Medicine

Stanley S Wang, MD, JD, MPH is a member of the following medical societies: Alpha Omega Alpha, American College of Cardiology, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, American Stroke Association, and Texas Medical Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Martin Gerard Keane, MD, FACC, FAHA  Associate Professor, Cardiovascular Medicine Division, Department of Medicine, University of Pennsylvania School of Medicine

Martin Gerard Keane, MD, FACC, FAHA is a member of the following medical societies: Alpha Omega Alpha, American College of Cardiology, American College of Physicians, American College of Physicians-American Society of Internal Medicine, American Heart Association, American Society of Echocardiography, Pennsylvania Medical Society, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Steven J Compton, MD, FACC, FACP  Director of Cardiac Electrophysiology, Alaska Heart Institute, Providence and Alaska Regional Hospitals

Steven J Compton, MD, FACC, FACP is a member of the following medical societies: Alaska State Medical Association, American College of Cardiology, American College of Physicians, American Heart Association, American Medical Association, and Heart Rhythm Society

Disclosure: Nothing to disclose.

Amer Suleman, MD  Private Practice

Amer Suleman, MD is a member of the following medical societies: American College of Physicians, American Heart Association, American Institute of Stress, American Society of Hypertension, Federation of American Societies for Experimental Biology, Royal Society of Medicine, and Society of Cardiac Angiography and Interventions

Disclosure: Nothing to disclose.

Chief Editor

Richard A Lange, MD  Professor and Executive Vice Chairman, Department of Medicine, Director, Office of Educational Programs, University of Texas Health Science Center at San Antonio

Richard A Lange, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Cardiology, American Heart Association, and Association of Subspecialty Professors

Disclosure: Nothing to disclose.

References
  1. Maurer G. Aortic regurgitation. Heart. Jul 2006;92(7):994-1000. [Medline].

  2. Singh JP, Evans JC, Levy D, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol. Mar 15 1999;83(6):897-902. [Medline].

  3. Feldman T. Rheumatic heart disease. Curr Opin Cardiol. Mar 1996;11(2):126-30. [Medline].

  4. Dujardin KS, Enriquez-Sarano M, Schaff HV, Bailey KR, Seward JB, Tajik AJ. Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study. Circulation. Apr 13 1999;99(14):1851-7. [Medline].

  5. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. Sep 23 2008;52(13):e1-142. [Medline]. [Full Text].

  6. Keane MG, Pyeritz RE. Medical management of Marfan syndrome. Circulation. May 27 2008;117(21):2802-13. [Medline]. [Full Text].

  7. Ortiz JT, Shin DD, Rajamannan NM. Approach to the patient with bicuspid aortic valve and ascending aorta aneurysm. Curr Treat Options Cardiovasc Med. Dec 2006;8(6):461-7. [Medline].

  8. Friedman T, Mani A, Elefteriades JA. Bicuspid aortic valve: clinical approach and scientific review of a common clinical entity. Expert Rev Cardiovasc Ther. Feb 2008;6(2):235-48. [Medline].

  9. Palazzi C, D' Angelo S, Lubrano E, Olivieri I. Aortic involvement in ankylosing spondylitis. Clin Exp Rheumatol. May-Jun 2008;26(3 Suppl 49):S131-4. [Medline].

  10. Schirmer M, Weidinger F, Sandhofer A, Gschwendtner A, Wiedermann C. Valvular disease and myocardial infarctions in a patient with Behçet disease. J Clin Rheumatol. Oct 2003;9(5):316-20. [Medline].

  11. Eberhardt RT, Dhadly M. Giant cell arteritis: diagnosis, management, and cardiovascular implications. Cardiol Rev. Mar-Apr 2007;15(2):55-61. [Medline].

  12. Chand EM, Freant LJ, Rubin JW. Aortic valve rheumatoid nodules producing clinical aortic regurgitation and a review of the literature. Cardiovasc Pathol. Nov-Dec 1999;8(6):333-8. [Medline].

  13. Jain D, Halushka MK. Cardiac pathology of systemic lupus erythematosus. J Clin Pathol. Jul 2009;62(7):584-92. [Medline].

  14. Moyssakis I, Tektonidou MG, Vasilliou VA, Samarkos M, Votteas V, Moutsopoulos HM. Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. Am J Med. Jul 2007;120(7):636-42. [Medline].

  15. Lee JL, Naguwa SM, Cheema GS, Gershwin ME. Revisiting Libman-Sacks endocarditis: a historical review and update. Clin Rev Allergy Immunol. Jun 2009;36(2-3):126-30. [Medline].

  16. Adachi O, Saiki Y, Akasaka J, Oda K, Iguchi A, Tabayashi K. Surgical management of aortic regurgitation associated with takayasu arteritis and other forms of aortitis. Ann Thorac Surg. Dec 2007;84(6):1950-3. [Medline].

  17. Jeserich M, Ihling C, Holubarsch C. Aortic valve endocarditis with Whipple disease. Ann Intern Med. Jun 1 1997;126(11):920. [Medline].

  18. Gaztanaga J, Pizarro G, Sanz J. Evaluation of cardiac valves using multidetector CT. Cardiol Clin. Nov 2009;27(4):633-44. [Medline].

  19. Morello A, Gelfand EV. Cardiovascular magnetic resonance imaging for valvular heart disease. Curr Heart Fail Rep. Sep 2009;6(3):160-6. [Medline].

  20. Myerson SG. Valvular and hemodynamic assessment with CMR. Heart Fail Clin. Jul 2009;5(3):389-400, vi-vii. [Medline].

  21. Picano E, Pibarot P, Lancellotti P, Monin JL, Bonow RO. The emerging role of exercise testing and stress echocardiography in valvular heart disease. J Am Coll Cardiol. Dec 8 2009;54(24):2251-60. [Medline].

  22. Bekeredjian R, Grayburn PA. Valvular heart disease: aortic regurgitation. Circulation. Jul 5 2005;112(1):125-34. [Medline].

  23. Bhudia SK, McCarthy PM, Kumpati GS, Helou J, Hoercher KJ, Rajeswaran J, et al. Improved outcomes after aortic valve surgery for chronic aortic regurgitation with severe left ventricular dysfunction. J Am Coll Cardiol. Apr 3 2007;49(13):1465-71. [Medline].

  24. Rahimtoola SH. Choice of Prosthetic Heart Valve in Adults An Update. J Am Coll Cardiol. Jun 1 2010;55(22):2413-2426. [Medline].

  25. Sampat U, Varadarajan P, Turk R, Kamath A, Khandhar S, Pai RG. Effect of beta-blocker therapy on survival in patients with severe aortic regurgitation results from a cohort of 756 patients. J Am Coll Cardiol. Jul 28 2009;54(5):452-7. [Medline].

  26. Bostwick DG, Bensch KG, Burke JS, Billingham ME, Miller DC, Smith JC, et al. Whipple's disease presenting as aortic insufficiency. N Engl J Med. Oct 22 1981;305(17):995-8. [Medline].

  27. Goldbarg SH, Halperin JL. Aortic regurgitation: disease progression and management. Nat Clin Pract Cardiovasc Med. May 2008;5(5):269-79. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.